A brand new episode of Shark Tank Season 13 will air this Friday, and it will feature an interesting deal related to mental health. Founder Liv B. will appear on the ABC show to pitch her business, ...
CAMBRIDGE, Mass., October 15, 2025--(BUSINESS WIRE)--Liberate Bio, Inc., a biotechnology company developing genetic medicines that deliver RNA therapies directly to immune cells, today announced new ...
Liberate, an AI startup automating insurance operations, has raised $50 million in a round led by Battery Ventures as it looks to scale its agentic deployments across carriers and agencies globally.
Liberate Bio has expanded its leadership team by bringing on former AstraZeneca drug-delivery head Shawn Davis as CEO, the Boston biotech announced Wednesday. Davis started in April, as did fellow ...
CAMBRIDGE, Mass.--(BUSINESS WIRE)--Liberate Bio, Inc., a biotechnology company developing medicines which efficiently and selectively deliver payloads to immune cells while bypassing the live, ...
Liberate Bio has obtained both exclusive and non-exclusive licences for patents related to chimeric antigen receptor (CAR) designs tailored for myeloid cells, such as monocytes and macrophages. The ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results